{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:28:10Z","timestamp":1782394090767,"version":"3.54.5"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T00:00:00Z","timestamp":1488153600000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1111\/bjd.15255","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T02:40:59Z","timestamp":1488249659000},"page":"281-282","source":"Crossref","is-referenced-by-count":13,"title":["<scp>NICE<\/scp>\n            approval of adalimumab for moderate\u2010to\u2010severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics?"],"prefix":"10.1093","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5257-1142","authenticated-orcid":false,"given":"J.R.","family":"Ingram","sequence":"first","affiliation":[{"name":"Department of Dermatology and Academic Wound Healing Division of Infection &amp; Immunity Cardiff University Cardiff U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Burton","sequence":"additional","affiliation":[{"name":"HS Trust Cliffe House St Anthonys Way Rochester U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12966"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504370"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13270"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1159\/000365390"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.06.050"},{"key":"e_1_2_3_7_1","unstructured":"National Institute for Health and Care Excellence.Adalimumab for treating moderate to severe hidradenitis suppurativa.London:NICE 2016. Available at:https:\/\/www.nice.org.uk\/guidance\/ta392(accessed 22 September 2016)."}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.15255","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.15255","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.15255","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.15255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:25:00Z","timestamp":1676384700000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/176\/2\/281\/6601817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":6,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,27]]},"published-print":{"date-parts":[[2017,2]]}},"alternative-id":["10.1111\/bjd.15255"],"URL":"https:\/\/doi.org\/10.1111\/bjd.15255","archive":["Portico"],"relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}